Want To Live Longer? Here's the Truth About Supplements, Peptides, VO2 Max, GLP-1's, and the Only Real Miracle Drug | Kara Swisher

What It Covers

Tech journalist Kara Swisher, host of HBO Max docuseries *Kara Swisher Wants to Live Forever*, separates longevity science from social media hype, evaluating peptides, VO2 max, GLP-1 drugs, full-body scans, and mRNA cancer vaccines, while identifying relationship quality and community as the strongest evidence-based predictors of longer life.

Key Questions Answered

• •Longevity Bullshit Detector: Most trending interventions — peptides (often sourced from unregulated Chinese labs), hyperbaric chambers, red light therapy, NAD infusions, and full-body scans — lack gold-standard scientific evidence. The pattern is consistent: anecdotal "I feel better" reports replace clinical proof, and each intervention is sold at premium prices to people who can afford to be misled.
• •VO2 Max as a Reliable Health Marker: VO2 max, which measures how efficiently the heart and muscles use oxygen during exertion, is one of the few metrics with strong scientific backing. Swisher raised her score from the low 30s to 37 by resuming treadmill running using interval training — alternating between heart rate zones and tracking recovery speed as the key variable.
• •Relationship Quality Outperforms Every Supplement: The Harvard Study of Adult Development, tracking thousands of participants across 90 years and multiple income levels, consistently identifies relationship quality as the single strongest predictor of longevity. Even brief positive interactions — asking a barista a follow-up question about their day — produce measurable cortisol and mood effects in both parties.
• •GLP-1 Drugs Extend Beyond Weight Loss: GLP-1 medications show emerging evidence for stroke prevention, cognitive health, and addiction reduction — not just obesity treatment. Swisher's cardiologist prescribed a low dose specifically to reduce stroke recurrence risk. Researchers argue universal access paired with nutrition and exercise education could collapse the current 14-year gap between U.S. health span (65) and life span (79).
• •mRNA Technology Is Targeting Pancreatic Cancer: Researchers at Memorial Sloan Kettering are developing personalized mRNA vaccines for pancreatic cancer — a disease where standard treatment yields six months to two years survival. Early trial participants receiving individualized mRNA vaccines targeting their specific tumor cells are surviving eight to nine years, fundamentally changing prognosis timelines for one of oncology's hardest-to-treat cancers.